Dr. Steven Kamara, MD

Dr. Kamara practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Kamara's NPI, 1275640336, was assigned on August 24, 2006. Dr. Kamara graduated from Albert Einstein College of Medicine in 1991. Dr. Kamara holds California license G07480.

Dr. Kamara's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Kamara's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center. Dmand AI also links Dr. Kamara to 5 more home health agencies, 2 skilled nursing facilities, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kamara practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Kamara's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Kamara is licensed in California.

Dmand AI lists acute diabetes, acute gastroduodenitis, acute kidney failure, acute sinusitis, acute skin infection, anemia, aneurysm and anxiety among the conditions Dr. Kamara treats.

CMS data shows 4,438 Medicare services from Dr. Kamara across 16 procedure codes in 2024, for 397 Medicare patients. Medicare paid $395,407 for them.

CMS counts 397 Medicare patients who saw Dr. Kamara in 2024. The largest group is 65 to 74, with 148 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 60% are also on Medicaid. Their average risk score is 2.26, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kamara's median patient age at 43, with 42% women.

In 2024, Dr. Kamara wrote 6,880 Medicare Part D claims for 363 patients. 80% of them were for generic drugs. CMS names the drug for 6,197 of them, across 149 drugs with 11 or more claims each, at $919,574 in total drug cost. In 2023, CMS named 6,571 claims across 143 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kamara for performance year 2024, reported as part of a group. Dr. Kamara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kamara as offering telehealth.

CMS Open Payments shows 859 general payments to Dr. Kamara from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Amgen Inc. paid the most, $7,758. It also lists 1 research payment totaling $450 in 2017.

Dmand AI lists 1 award for Dr. Kamara, most recently CMS Stage 1 EHR in 2013.

Dr. Kamara graduated from Albert Einstein College of Medicine in 1991.

Dr. Kamara is in network with 7 carriers, including Blue Cross Blue Shield of Michigan, Aetna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.